We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.35 | 11.3636363636 | 3.08 | 3.6 | 3.001 | 47307 | 3.18915985 | CS |
4 | 0.72 | 26.5682656827 | 2.71 | 3.6 | 2.5601 | 45216 | 3.07663107 | CS |
12 | -0.32 | -8.53333333333 | 3.75 | 4.81 | 2.56 | 77729 | 3.49902974 | CS |
26 | -0.17 | -4.72222222222 | 3.6 | 23.8 | 2.56 | 1501845 | 11.20522815 | CS |
52 | -1.85 | -35.0378787879 | 5.28 | 23.8 | 2.56 | 830538 | 10.64216862 | CS |
156 | -329.57 | -98.96996997 | 333 | 392.382 | 2.56 | 377067 | 28.70361951 | CS |
260 | -1031.57 | -99.6685990338 | 1035 | 1302.75 | 2.56 | 297046 | 184.2795296 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions